It has been shown that there is a significant decrease in the number of CD4+Foxp3+ T cells as well as the expression level of Foxp3 in relapsing-remitting MS and other lymphoproliferative autoimmune disorders [6, 8, 38]. This evidence concerns the gene FOXP3 and relapsing-remitting multiple sclerosis.